NIH Stock Overview
Engages in the financial and real estate investing, and industrial activities. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
National International Holding Company K.S.C.P. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | د.ك0.41 |
52 Week High | د.ك0.50 |
52 Week Low | د.ك0.087 |
Beta | 0.42 |
11 Month Change | 79.13% |
3 Month Change | 346.85% |
1 Year Change | 267.86% |
33 Year Change | 161.96% |
5 Year Change | 618.72% |
Change since IPO | 70.44% |
Recent News & Updates
Recent updates
Shareholder Returns
NIH | KW Diversified Financial | KW Market | |
---|---|---|---|
7D | 15.7% | 2.1% | 0.3% |
1Y | 267.9% | 22.1% | 10.2% |
Return vs Industry: NIH exceeded the KW Diversified Financial industry which returned 22.1% over the past year.
Return vs Market: NIH exceeded the KW Market which returned 10.2% over the past year.
Price Volatility
NIH volatility | |
---|---|
NIH Average Weekly Movement | 17.1% |
Diversified Financial Industry Average Movement | 6.7% |
Market Average Movement | 4.6% |
10% most volatile stocks in KW Market | 13.1% |
10% least volatile stocks in KW Market | 2.0% |
Stable Share Price: NIH's share price has been volatile over the past 3 months compared to the KW market.
Volatility Over Time: NIH's weekly volatility has increased from 9% to 17% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1979 | n/a | Mamdouh Abdul Ghani Sherbiny | nih-kw.com |
National International Holding Company K.S.C.P., together with its subsidiaries, engages in the financial and real estate investing, and industrial activities. The company’s Financial Investing segment participates in financial and real estate funds. Its Real Estate Investing segment invests in, trades in, constructs or develops, and sells real estate properties and other related real estate services.
National International Holding Company K.S.C.P. Fundamentals Summary
NIH fundamental statistics | |
---|---|
Market cap | د.ك95.47m |
Earnings (TTM) | د.ك2.21m |
Revenue (TTM) | د.ك7.42m |
43.2x
P/E Ratio12.9x
P/S RatioIs NIH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NIH income statement (TTM) | |
---|---|
Revenue | د.ك7.42m |
Cost of Revenue | د.ك3.15m |
Gross Profit | د.ك4.27m |
Other Expenses | د.ك2.05m |
Earnings | د.ك2.21m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.0095 |
Gross Margin | 57.50% |
Net Profit Margin | 29.80% |
Debt/Equity Ratio | 5.1% |
How did NIH perform over the long term?
See historical performance and comparison